(Q53605401)

16 May 2018

title

Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis. (English)

1 reference

16 May 2018

author name string

Maarten A de Jong

1

1 reference

16 May 2018

Katarina Mirkovic

2

1 reference

16 May 2018

Rik Mencke

3

1 reference

16 May 2018

Joost G Hoenderop

4

1 reference

16 May 2018

René J Bindels

5

1 reference

16 May 2018

Marc G Vervloet

6

1 reference

16 May 2018

Jan-Luuk Hillebrands

7

1 reference

16 May 2018

Jacob van den Born

8

1 reference

16 May 2018

Gerjan Navis

9

1 reference

16 May 2018

Martin H de Borst

10

1 reference

16 May 2018

NIGRAM consortium

11

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 January 2017

1 reference

16 May 2018

Nephrology Dialysis Transplantation

published in

1 reference

16 May 2018

volume

32

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

73-80

1 reference

16 May 2018

Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Klotho, phosphate and inflammation/ageing in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFW105

21 January 2018

Identifiers

DOI

10.1093/NDT/GFW105

1 reference

16 May 2018

1 reference

16 May 2018